Rituximab (MabThera®) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation
oleh: C Knight, D Hind, N Brewer, V Abbott
| Format: | Article |
|---|---|
| Diterbitkan: | NIHR Journals Library 2004-09-01 |
Deskripsi
No description available for this item.